TNF and inflammatory bowel disease: According to Korean IBD treatment guidelines, systemic steroids or other immunosuppressive agents should be prescribed only to patients with moderate or severe diseases, and anti-TNF therapy is typically delayed until the second exacerbation event, or until the patient is unresponsive to, or dependent on, steroids (or immune-suppressants) for at least 3 months after the diagnosis of IBD.